Stocks · Health care · Pharmaceutical Preparations

TEVA PHARMACEUTICAL INDUSTRIES LTD

TEVA Clue Score52
Israel Fiscal year ends December CIK 0000818686 Results filed 3 Nov 2026

What the insiders did Net selling

Insider
Date
Role
Action
Shares
Price
Amount
Roberto Mignone
18 Sep 2026
Director
Sell indirect
367,600
$39.06
$14.36M
Ronit Satchi-Fainaro
21 Aug 2026
Director
Sell
415
$37.25
$15.46K
Tal Zvi Zaks
5 Aug 2026
Director
Sell
17
$34.87
$592.71
Matthew Shields
18 Jun 2026
EVP, Global Operations
Sell
9,989
$32.19
$321.55K
Amir Weiss
6 May 2026
Chief Accounting Officer
Sell
10,679
$36.00
$384.44K
Richard Daniell
5 May 2026
EVP, Europe Commercial
Sell
30,000
$35.40
$1.06M
Mark Sabag
1 May 2026
See "Remarks"
Sell
144,180
$34.99
$5.05M
Christine Fox
30 Apr 2026
EVP, U.S. Commercial
Sell
21,258
$35.31
$750.62K
Mark Sabag
17 Mar 2026
See "Remarks"
Sell
62,102
$30.14
$1.87M
Roberto Mignone
16 Dec 2025
Director
Sell indirect
77,400
$30.24
$2.34M
Amir Weiss
16 Dec 2025
Chief Accounting Officer
Sell
12,300
$30.20
$371.50K
Roberto Mignone
26 Nov 2025
Director
Sell indirect
50,000
$26.03
$1.30M
Christine Fox
14 Nov 2025
EVP, Head of U.S. Commercial
Sell
30,000
$25.11
$753.32K
Amir Weiss
6 Nov 2025
Chief Accounting Officer
Sell
12,300
$24.44
$300.56K
Roberto Mignone
6 Nov 2025
Director
Sell indirect
200,000
$24.11
$4.82M
Mark Sabag
8 May 2025
See "Remarks"
Sell
337,915
$18.04
$6.10M
Mark Sabag
12 Feb 2025
See "Remarks"
Sell
177,626
$16.25
$2.89M
Roberto Mignone
20 Dec 2024
Director
Sell indirect
286,000
$22.01
$6.29M
Richard Daniell
12 Aug 2024
Exec. VP, European Commercial
Sell
98,943
$17.30
$1.71M
Eric A Hughes
9 Aug 2024
See "Remarks"
Sell
45,060
$17.38
$782.97K
Roberto Mignone
18 Jun 2024
Director
Sell indirect
519,000
$17.03
$8.84M
Amir Weiss
16 May 2024
Chief Accounting Officer
Sell
12,635
$16.65
$210.38K
Amir Weiss
15 May 2024
Chief Accounting Officer
Sell
15,500
$16.80
$260.42K
Vikki L Conway
13 May 2024
See "Remarks"
Sell
15,219
$16.74
$254.81K
Eric Drape
16 Feb 2024
Executive VP Global Operations
Sell
173,261
$13.05
$2.26M
Amir Weiss
1 Feb 2024
Chief Accounting Officer
Sell
31,766
$12.37
$392.95K
Eliyahu Sharon Kalif
7 Aug 2023
EVP, Chief Financial Officer
Sell
35,125
$9.73
$341.89K
Amir Weiss
4 Aug 2023
Chief Accounting Officer
Sell
1,981
$9.92
$19.66K
Richard Daniell
7 Mar 2023
Exec. VP, European Commercial
Sell
54,007
$9.43
$509.17K
Sven Dethlefs
7 Mar 2023
EVP, North America Commercial
Sell
58,066
$9.43
$547.44K
Eric Drape
7 Mar 2023
Executive VP Global Operations
Sell
4,699
$9.43
$44.30K
David Matthew Stark
7 Mar 2023
Exec. VP Chief Legal Officer
Sell
49,475
$9.43
$466.45K
Richard Daniell
6 Mar 2023
Exec. VP, European Commercial
Sell
18,002
$9.93
$178.78K
Sven Dethlefs
6 Mar 2023
EVP, North America Commercial
Sell
19,355
$9.93
$192.21K
Eric Drape
6 Mar 2023
Executive VP Global Operations
Sell
1,566
$9.93
$15.55K
David Matthew Stark
6 Mar 2023
Exec. VP Chief Legal Officer
Sell
16,491
$9.93
$163.77K
Eliyahu Sharon Kalif
22 Aug 2022
EVP, Chief Financial Officer
Sell
55,500
$10.07
$558.70K
David Matthew Stark
28 Jul 2022
Exec. VP Chief Legal Officer
Sell
58,163
$9.04
$525.59K
Hafrun Fridriksdottir
17 May 2022
Executive VP, Global R&D
Sell
130,000
$8.22
$1.07M
Richard Daniell
7 Mar 2022
Exec. VP, European Commercial
Sell
22,576
$7.37
$166.31K
Sven Dethlefs
7 Mar 2022
EVP, North America Commercial
Sell
6,993
$7.37
$51.52K
Eric Drape
7 Mar 2022
Executive VP Global Operations
Sell
11,334
$7.37
$83.49K
Hafrun Fridriksdottir
7 Mar 2022
Executive VP, Global R&D
Sell
8,941
$7.37
$65.87K
David Matthew Stark
7 Mar 2022
Exec. VP Chief Legal Officer
Sell
9,057
$7.37
$66.72K
Hafrun Fridriksdottir
10 Aug 2021
Executive VP, Global R&D
Sell
50,860
$9.95
$506.02K
Eric Drape
21 May 2021
Executive VP Global Operations
Sell
40,000
$11.01
$440.32K
Mark Sabag
16 Mar 2021
See "Remarks" below
Sell
127,244
$11.22
$1.43M
Brendan P. O'Grady
5 Mar 2021
EVP, North America Commercial
Sell
11,436
$10.54
$120.58K
Hafrun Fridriksdottir
2 Mar 2021
Executive VP, Global R&D
Sell
50,000
$10.82
$540.89K
Brendan P. O'Grady
2 Mar 2021
EVP, North America Commercial
Sell
15,085
$10.85
$163.60K
Richard Daniell
1 Mar 2021
Exec. VP, European Commercial
Sell
20,598
$10.85
$223.51K
Sven Dethlefs
1 Mar 2021
EVP Global Marketing&Portfolio
Sell
7,486
$10.83
$81.08K
Eric Drape
1 Mar 2021
Executive VP Global Operations
Sell
9,795
$10.85
$106.28K
Hafrun Fridriksdottir
1 Mar 2021
Executive VP, Global R&D
Sell
10,912
$10.83
$118.19K
Gianfranco Nazzi
1 Mar 2021
EVP, International Markets
Sell
60,410
$10.88
$657.24K
Gianfranco Nazzi
1 Mar 2021
EVP, International Markets
Sell
15,177
$10.85
$164.68K
Brendan P. O'Grady
1 Mar 2021
EVP, North America Commercial
Sell
63,278
$10.93
$691.35K
Brendan P. O'Grady
1 Mar 2021
EVP, North America Commercial
Sell
9,849
$10.83
$106.67K
David Matthew Stark
1 Mar 2021
Exec. VP Chief Legal Officer
Sell
18,430
$10.83
$199.61K
Eric Drape
16 Feb 2021
Executive VP Global Operations
Sell
2,079
$11.13
$23.14K
Hafrun Fridriksdottir
16 Feb 2021
Executive VP, Global R&D
Sell
2,098
$11.12
$23.34K
David Matthew Stark
16 Feb 2021
Exec. VP Chief Legal Officer
Sell
3,926
$11.12
$43.67K
Eric Drape
19 Feb 2020
Executive VP Global Operations
Sell
8,000
$12.51
$100.08K
Mark Sabag
13 Feb 2020
See "Remarks" below
Sell
72,131
$13.03
$939.76K
Richard Daniell
10 Feb 2020
Exec. VP, European Commercial
Sell
6,199
$12.24
$75.89K
Sven Dethlefs
10 Feb 2020
EVP Global Marketing&Portfolio
Sell
5,669
$12.27
$69.56K
Eric Drape
10 Feb 2020
Executive VP Global Operations
Sell
3,144
$12.24
$38.49K
Hafrun Fridriksdottir
10 Feb 2020
Executive VP, Global R&D
Sell
5,544
$12.27
$68.02K
Gianfranco Nazzi
10 Feb 2020
EVP, Growth Markets Commercial
Sell
4,155
$12.24
$50.86K
Brendan P. O'Grady
10 Feb 2020
EVP, North America Commercial
Sell
4,799
$12.27
$58.88K
David Matthew Stark
10 Feb 2020
Exec. VP Chief Legal Officer
Sell
12,538
$12.24
$153.47K
Hafrun Fridriksdottir
2 Dec 2019
Executive VP, Global R&D
Sell
4,310
$10.49
$45.21K
Showing 250 of 313 transactions. The figures above use every one of them.

What was left out

Form 4 filings counted 596
Amendments (4/A) skipped 1
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 20
Sales straight out of an exercise 180
Sales at will 107
Transactions with no price 0
Shares from compensation/vesting 11,881,795
Sales filed before the plan box existed 79
History held since 24 Jul 2008